NIPPON EXPRESS HOLDINGS Strengthens Pharmaceutical Logistics Quality System Globally

NIPPON EXPRESS HOLDINGS, INC., based in Tokyo, has compiled the NX-Pharma Global Quality Manual, applicable as of Sunday, January 1, 2023, to uni...

 March 09, 2023 | News

Mallinckrodt's CELLEX® ECP System Reimbursed in Japan for cGvHD Treatment

– CELLEX ECP is now available for reimbursement in Japan for patients who are steroid-resistant or -intolerant and suffering from cGvHD &nd...

 March 09, 2023 | News

Saitama Medical University International Medical Center joins TriNetX network to study rare disease treatments globally.

Saitama Medical University International Medical Center, one of Japan's leading hospitals for the treatment of oncology, cardiology, and stroke c...

 March 07, 2023 | News

C2i Genomics Expands to Japan, Announces Collab with Riken Genesis

The collaboration will expand C2i’s global reach and bring MRD cancer monitoring capabilities for solid tumors to Japan     C2i Genomics...

 March 03, 2023 | News

Biogen Japan and Eisai Provide Update on Co-Promotion Of Multiple Sclerosis Treatments In Japan

The two companies have been jointly engaged in promotional activities for MS treatments in Japan. However, since a certain objective has been achieved rega...

 March 02, 2023 | News

Olympus to Acquire Korean Gastrointestinal Stent Company Taewoong Medical Co., Ltd

Olympus Corporation (Olympus), a global medtech company committed to making people's lives healthier, safer and more fulfilling, has agreed to acquire Taew...

 February 24, 2023 | News

Ajinomoto Bio-Pharma Services Successfully Develops Highly Functional Ancestral RNA Ligase

In collaboration with researchers from the University of Shizuoka, Aji Bio-Pharma succeeded in developing a highly functional artificial RNA ligase using t...

 February 23, 2023 | News

Nippon Express Singapore obtains IATA CEIV Pharma for Changi facility

The pharmaceutical/medical sector, one of Singapore's priority industries, has seen remarkable growth, and many of the world's leading pharmaceut...

 February 22, 2023 | News

Recce Pharmaceuticals Announces RECCE® Trademark Registered in Hong Kong

Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) (the Company), the Company developing a new class of synthetic anti-infectives, today announced that it has ...

 February 03, 2023 | News

Lecanemab Receives Priority Review Status in Japan

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Chri...

 January 30, 2023 | News

Strength in sustainability: Vetter wins gold in EcoVadis ranking

  Vetter among the top five percent in the industry Result acknowledges strong sustainability commitment to the environment, social sector and...

 January 18, 2023 | News

Eisai Files Marketing Authorization Application for Anti-Amyloid-Beta Protofibril Antibody Lecanemab for Early Alzheimer's Disease in Japan

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Mass...

 January 16, 2023 | News

Ajinomoto and Exelixis Enter Into a License Agreement to Discover and Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer

Exelixis is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, development and commercialization o...

 January 11, 2023 | News

Ubitus and Smart Surgery enable doctors to practice robotic surgery with VR streaming

Immersive simulation surgery practice with VR gears Ample practices are required for a medical student or even a doctor to become a skillful surgeon opera...

 December 23, 2022 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in